| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42b66fd6ac8d432f925152eef843ebe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_436b489653124a7c40658a96293b471c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate |
2002-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0c1bd5c41106bc6e2929e512608a75a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95ee444c0b3b9274fe75902630fb2b99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db76d360efe02feba5cfa7868e944aad |
| publicationDate |
2012-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NO-332215-B1 |
| titleOfInvention |
Stabilized aqueous suspension formulation for parenteral administration, its use and ampoule containing the formulation |
| abstract |
Pharmaceutical aqueous suspension formulation for parenteral administration with substantially stabilized pH comprising a biologically active compound and a pH-regulating effective concentration of L-methionine. Preferably, the biologically active compound is a steroid compound e.g. exemestane, medroxyprogesterone acetate and estradiol cypionate or a combination of medroxyprogesterone acetate and estradiol cypionate. |
| priorityDate |
2000-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |